NXL
NXL
NASDAQ · Health Care

Nexalin Technology Inc

$1.51
+0.02 (+1.34%)
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +460.9% upside
Low Target $5.74
Average Target $8.47
High Target $10.28
Current Price $1.51
Current
$1.51
Target
$8.47
$5.74 $8.47 avg $10.28
Scenario Analysis
Bear Case
$5.74
280.1%
Low target
Base Case
$8.47
+460.9%
Avg target
Bull Case
$10.28
+580.8%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$43.50
-96.5% from high
52-Week Low
$1.31
+15.3% from low
Target vs 52W High
$8.47
-80.5% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Strong Buy 32 84% $293.85 -27.5%
ABT
Abbott Laboratories
Strong Buy 33 79% $123.47 +13.7%
ISRG
Intuitive Surgical Inc
Strong Buy 40 75% $219.77 -50.7%
MDT
Medtronic Plc
Buy 35 66% $192.46 +90.6%
SYK
Stryker Corp
Strong Buy 35 77% $338.36 +8.8%
MCK
Mckesson Corp
Strong Buy 22 82% $307.39 -71.9%
CVS
Cvs Health Corp
Strong Buy 32 88% $162.09 +80.5%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.2%